Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/20/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Immunotherapy approaches for the treatment of diffuse midline gliomas.

Condition: Diffuse Midline Gliomas (DMG)
Journal: Oncoimmunology
Treatment Used: Immunotherapy
Number of Patients: 0
Published: October 03, 2022

Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.

Condition: Pediatric Diffuse Intrinsic-Pontine Glioma
Journal: The New England journal of medicine
Treatment Used: Oncolytic DNX-2401
Number of Patients: 12
Published: June 29, 2022

Nimotuzumab as Additional Therapy for GLIOMA in Pediatric and Adolescent: A Systematic Review.

Condition: Children and Adolescents with Glioma
Journal: Cancer control : journal of the Moffitt Cancer Center
Treatment Used: Nimotuzumab
Number of Patients: 151
Published: February 22, 2022

Impact of ComBat and a Multi-Model approach to deal with multi-scanner and missing MRI data in a small cohort study. Application to H3K27M mutation prediction in patients with DIPG.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: December 11, 2021

Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas.

Journal: Nature communications
Published: February 13, 2021

Pilot Study of Hyperpolarized 13C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers.

Journal: AJNR. American journal of neuroradiology
Published: December 04, 2020

Hypofractionated radiotherapy versus conventional radiotherapy for diffuse intrinsic pontine glioma: A systematic review and meta-analysis.

Condition: Diffuse Intrinsic Pontine Glioma
Journal: Medicine
Treatment Used: Hypofractionated Radiotherapy Versus Conventional Radiotherapy
Number of Patients: 184
Published: October 21, 2020

Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG.

Journal: Cell reports
Published: October 21, 2020

Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience.

Condition: Children with Diffuse Intrinsic Pontine Gliomas (DIPGs) and High-Grade Glioma
Journal: Journal of neuro-oncology
Treatment Used: Temozolomide, Irinotecan, and Bevacizumab (TIB)
Number of Patients: 36
Published: June 20, 2020

A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.

Condition: Diffuse Intrinsic Pontine Glioma (DIPG) or High-Grade Glioma (HGG) in Children
Journal: Pediatric blood & cancer
Treatment Used: Valproic Acid (VPA) and Bevacizumab
Number of Patients: 38
Published: April 15, 2020

Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.

Condition: Diffuse Intrinsic Pontine Glioma (DIPG)
Journal: Journal of neuro-oncology
Treatment Used: Radiation Therapy (RT)
Number of Patients: 108
Published: February 05, 2020

A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.

Condition: Diffuse Pontine Glioma
Journal: Neuro-oncology
Treatment Used: Veliparib with Radiation and Temozolomide
Number of Patients: 65
Published: February 04, 2020
Showing 1-12 of 18

Last Updated: 01/20/2023